{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:43:23Z","timestamp":1790772203127,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Blood Cancer UK\/Grant Number 16001"},{"DOI":"10.13039\/501100001273","name":"CHILDREN with CANCER UK","doi-asserted-by":"publisher","award":["17-250"],"award-info":[{"award-number":["17-250"]}],"id":[{"id":"10.13039\/501100001273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001273","name":"CHILDREN with CANCER UK","doi-asserted-by":"publisher","award":["17-250"],"award-info":[{"award-number":["17-250"]}],"id":[{"id":"10.13039\/501100001273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N000838\/1"],"award-info":[{"award-number":["MR\/N000838\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The ETV6-RUNX1 onco-fusion arises <jats:italic>in utero<\/jats:italic>, initiating a clinically silent pre-leukemic state associated with the development of pediatric B-acute lymphoblastic leukemia (B-ALL). We characterize the ETV6-RUNX1 regulome by integrating chromatin immunoprecipitation- and RNA-sequencing and show that ETV6-RUNX1 functions primarily through competition for RUNX1 binding sites and transcriptional repression. In pre-leukemia, this results in ETV6-RUNX1 antagonization of cell cycle regulation by RUNX1 as evidenced by mass cytometry analysis of B-lineage cells derived from ETV6-RUNX1 knock-in human pluripotent stem cells. In frank leukemia, knockdown of RUNX1 or its co-factor CBF\u03b2 results in cell death suggesting sustained requirement for RUNX1 activity which is recapitulated by chemical perturbation using an allosteric CBF\u03b2-inhibitor. Strikingly, we show that RUNX1 addiction extends to other genetic subtypes of pediatric B-ALL and also adult disease. Importantly, inhibition of RUNX1 activity spares normal hematopoiesis. Our results suggest that chemical intervention in the RUNX1 program may provide a therapeutic opportunity in ALL.<\/jats:p>","DOI":"10.1038\/s41467-022-34653-3","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T05:02:39Z","timestamp":1669006959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Regulome analysis in B-acute lymphoblastic leukemia exposes Core Binding Factor addiction as a therapeutic vulnerability"],"prefix":"10.1038","volume":"13","author":[{"given":"Jason P.","family":"Wray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elitza M.","family":"Deltcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4876-1218","authenticated-orcid":false,"given":"Charlotta","family":"Boiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4343-4784","authenticated-orcid":false,"given":"Simon \u0415","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti Bikram","family":"Chhetri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7463-3503","authenticated-orcid":false,"given":"John","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sladjana","family":"Gagrica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7398-3181","authenticated-orcid":false,"given":"Anuradha","family":"Illendula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost H. A.","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0066-1576","authenticated-orcid":false,"given":"Hendrik G.","family":"Stunnenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5386-1758","authenticated-orcid":false,"given":"John H.","family":"Bushweller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6213-9030","authenticated-orcid":false,"given":"Rachael","family":"Nimmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0866-6443","authenticated-orcid":false,"given":"Tariq","family":"Enver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"key":"34653_CR1","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","volume":"373","author":"SP Hunger","year":"2015","unstructured":"Hunger, S. P. & Mullighan, C. G. Acute lymphoblastic leukemia in children. N. Engl. J. Med. 373, 1541\u20131552 (2015).","journal-title":"N. Engl. J. Med."},{"key":"34653_CR2","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1111\/bcp.14403","volume":"87","author":"U Greenbaum","year":"2021","unstructured":"Greenbaum, U. et al. Chimeric antigen receptor T-cell therapy toxicities. Br. J. Clin. Pharmacol. 87, 2414\u20132424 (2021).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"34653_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41568-018-0015-6","volume":"18","author":"M Greaves","year":"2018","unstructured":"Greaves, M. A causal mechanism for childhood acute lymphoblastic leukaemia. Nat. Rev. Cancer 18, 471\u2013484 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"34653_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrc1164","volume":"3","author":"MF Greaves","year":"2003","unstructured":"Greaves, M. F. & Wiemels, J. Origins of chromosome translocations in childhood leukaemia. Nat. Rev. Cancer 3, 639\u2013649 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"34653_CR5","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1182\/blood-2017-09-808402","volume":"131","author":"D Sch\u00e4fer","year":"2018","unstructured":"Sch\u00e4fer, D. et al. Five percent of healthy newborns have an ETV6-RUNX1 fusion as revealed by DNA-based GIPFEL screening. Blood 131, 821\u2013826 (2018).","journal-title":"Blood"},{"key":"34653_CR6","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature05690","volume":"44","author":"CG Mullighan","year":"2007","unstructured":"Mullighan, C. G. et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 44, 758\u2013764 (2007).","journal-title":"Nature"},{"key":"34653_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1182\/blood-2008-07-166801","volume":"113","author":"S Sulong","year":"2009","unstructured":"Sulong, S. et al. A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. Blood 113, 100\u2013107 (2009).","journal-title":"Blood"},{"key":"34653_CR8","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1349-7006.2007.00443.x","volume":"98","author":"S Tsuzuki","year":"2007","unstructured":"Tsuzuki, S. et al. Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: Analysis by means of array-based comparative genomic hybridization. Cancer Sci. 98, 698\u2013706 (2007).","journal-title":"Cancer Sci."},{"key":"34653_CR9","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1182\/blood.V96.7.2557","volume":"96","author":"F Guidez","year":"2000","unstructured":"Guidez, F. et al. Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein. Blood 96, 2557\u20132561 (2000).","journal-title":"Blood"},{"key":"34653_CR10","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1128\/MCB.16.4.1349","volume":"16","author":"SW Hiebert","year":"1996","unstructured":"Hiebert, S. W. et al. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol. Cell Biol. 16, 1349\u20131355 (1996).","journal-title":"Mol. Cell Biol."},{"key":"34653_CR11","doi-asserted-by":"publisher","first-page":"4404","DOI":"10.1038\/sj.onc.1210227","volume":"26","author":"M Morrow","year":"2007","unstructured":"Morrow, M., Samanta, A., Kioussis, D., Brady, H. J. M. & Williams, O. TEL-AML1 preleukemic activity requires the DNA binding domain of AML1 and the dimerization and corepressor binding domains of TEL. Oncogene 26, 4404\u20134414 (2007).","journal-title":"Oncogene"},{"key":"34653_CR12","first-page":"4075","volume":"59","author":"JL Wiemels","year":"1999","unstructured":"Wiemels, J. L. & Greaves, M. Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia. Cancer Res. 59, 4075\u20134082 (1999).","journal-title":"Cancer Res."},{"key":"34653_CR13","doi-asserted-by":"publisher","first-page":"e26348","DOI":"10.1371\/journal.pone.0026348","volume":"6","author":"G Fuka","year":"2011","unstructured":"Fuka, G., Kauer, M., Kofler, R., Haas, O. A. & Panzer-Gr\u00fcmayer, R. The leukemia-specific fusion gene etv6\/runx1 perturbs distinct key biological functions primarily by gene repression. PLoS ONE 6, e26348 (2011).","journal-title":"PLoS ONE"},{"key":"34653_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2013.48","volume":"3","author":"Y Linka","year":"2013","unstructured":"Linka, Y. et al. The impact of TEL-AML1 (ETV6-RUNX1) expression in precursor B cells and implications for leukaemia using three different genome-wide screening methods. Blood Cancer J. 3, e151 (2013).","journal-title":"Blood Cancer J."},{"key":"34653_CR15","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1101\/gr.193649.115","volume":"26","author":"S Teppo","year":"2016","unstructured":"Teppo, S. et al. Genome-wide repression of eRNA and target gene loci by the ETV6-RUNX1 fusion in acute leukemia. Genome Res. 26, 1468\u20131477 (2016).","journal-title":"Genome Res."},{"key":"34653_CR16","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.celrep.2013.08.020","volume":"4","author":"O Ben-Ami","year":"2013","unstructured":"Ben-Ami, O. et al. Addiction of t(8;21) and inv(16) Acute Myeloid Leukemia to Native RUNX1. Cell Rep. 4, 1131\u20131143 (2013).","journal-title":"Cell Rep."},{"key":"34653_CR17","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.celrep.2014.08.024","volume":"8","author":"A Ptasinska","year":"2014","unstructured":"Ptasinska, A. et al. Identification of a dynamic core transcriptional network in t(8;21) AML that regulates differentiation block and self-renewal. Cell Rep. 8, 1974\u20131988 (2014).","journal-title":"Cell Rep."},{"key":"34653_CR18","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1038\/sj.onc.1207779","volume":"23","author":"M Osato","year":"2004","unstructured":"Osato, M. Point mutations in the RUNX1\/AML1 gene: another actor in RUNX leukemia. Oncogene 23, 4284\u20134296 (2004).","journal-title":"Oncogene"},{"key":"34653_CR19","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/sj.leu.2403471","volume":"18","author":"A Attarbaschi","year":"2004","unstructured":"Attarbaschi, A. et al. Incidence and relevance of secondary chromosome abnormalities in childhood TEL\/AML1 + acute lymphoblastic leukemia: an interphase FISH analysis. Leukemia 18, 1611\u20131616 (2004).","journal-title":"Leukemia"},{"key":"34653_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/sj.leu.2402399","volume":"16","author":"FM Mikhail","year":"2002","unstructured":"Mikhail, F. M. et al. AML1 gene over-expression in childhood acute lymphoblastic leukemia. Leukemia 16, 658\u2013668 (2002).","journal-title":"Leukemia"},{"key":"34653_CR21","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1172\/JCI61203","volume":"122","author":"CG Mullighan","year":"2012","unstructured":"Mullighan, C. G. Molecular genetics of B-precursor acute lymphoblastic leukemia. J. Clin. Investig. 122, 3407\u20133415 (2012).","journal-title":"J. Clin. Investig."},{"key":"34653_CR22","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1182\/blood-2017-03-775536","volume":"130","author":"AH Choi","year":"2017","unstructured":"Choi, Ah. et al. RUNX1 is required for oncogenic Myb and Myc enhancer activity in T-cell acute lymphoblastic leukemia. Blood 130, 1722\u20131733 (2017).","journal-title":"Blood"},{"key":"34653_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.celrep.2012.12.016","volume":"3","author":"AC Wilkinson","year":"2013","unstructured":"Wilkinson, A. C. et al. RUNX1 Is a Key Target in t(4;11) Leukemias that contributes to gene activation through an AF4-MLL complex interaction. Cell Rep. 3, 116\u2013127 (2013).","journal-title":"Cell Rep."},{"key":"34653_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ebiom.2016.04.032","volume":"8","author":"A Illendula","year":"2016","unstructured":"Illendula, A. et al. Small molecule inhibitor of CBF\u03b2-RUNX binding for RUNX transcription factor driven cancers. EBioMedicine 8, 117\u2013131 (2016).","journal-title":"EBioMedicine"},{"key":"34653_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1182\/blood-2013-01-480244","volume":"122","author":"B Niebuhr","year":"2013","unstructured":"Niebuhr, B. et al. Runx1 is essential at two stages of early murine B-cell development. Blood 122, 413\u2013423 (2013).","journal-title":"Blood"},{"key":"34653_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/sj.leu.2400571","volume":"11","author":"CC Uphoff","year":"1997","unstructured":"Uphoff, C. C. et al. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines. Leukemia 11, 441\u2013447 (1997).","journal-title":"Leukemia"},{"key":"34653_CR27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","volume":"51","author":"Z Gu","year":"2019","unstructured":"Gu, Z. et al. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat. Genet. 51, 296\u2013307 (2019).","journal-title":"Nat. Genet."},{"key":"34653_CR28","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.devcel.2017.12.005","volume":"44","author":"C B\u00f6iers","year":"2018","unstructured":"B\u00f6iers, C. et al. A human IPS model implicates embryonic B-myeloid fate restriction as developmental susceptibility to B acute lymphoblastic leukemia-associated ETV6-RUNX1. Dev. Cell 44, 362\u2013377 (2018).","journal-title":"Dev. Cell"},{"key":"34653_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"34653_CR30","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34653_CR31","first-page":"826","volume":"119","author":"AM Ford","year":"2009","unstructured":"Ford, A. M. et al. The TEL-AML1 leukemia fusion gene dysregulates the TGF-\u03b2 pathway in early B lineage progenitor cells. J. Clin. Investig. 119, 826\u2013836 (2009).","journal-title":"J. Clin. Investig."},{"key":"34653_CR32","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1182\/blood-2003-10-3695","volume":"103","author":"M Morrow","year":"2004","unstructured":"Morrow, M., Horton, S., Kioussis, D., Brady, H. J. M. & Williams, O. TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity. Blood 103, 3890\u20133896 (2004).","journal-title":"Blood"},{"key":"34653_CR33","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.ccell.2016.11.002","volume":"30","author":"S Ebinger","year":"2016","unstructured":"Ebinger, S. et al. Characterization of rare, dormant, and therapy-resistant cells in acute lymphoblastic leukemia. Cancer Cell 30, 849\u2013862 (2016).","journal-title":"Cancer Cell"},{"issue":"5","key":"34653_CR34","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/leu.2012.306","volume":"27","author":"C Lutz","year":"2013","unstructured":"Lutz, C. et al. Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia. Leukemia 27, 1204\u20131207 (2013).","journal-title":"Leukemia"},{"key":"34653_CR35","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/cyto.a.22075","volume":"81","author":"GK Behbehani","year":"2012","unstructured":"Behbehani, G. K., Bendall, S. C., Clutter, M. R., Fantl, W. J. & Nolan, G. P. Single-cell mass cytometry adapted to measurements of the cell cycle. Cytometry A 81, 552\u2013566 (2012).","journal-title":"Cytometry A"},{"key":"34653_CR36","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1182\/blood-2010-08-299941","volume":"117","author":"L Carpenter","year":"2011","unstructured":"Carpenter, L. et al. Human induced pluripotent stem cells are capable of B-cell lymphopoiesis. Blood 117, 4008\u20134011 (2011).","journal-title":"Blood"},{"key":"34653_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17146-z","volume":"11","author":"BR Pennycook","year":"2020","unstructured":"Pennycook, B. R. et al. E2F-dependent transcription determines replication capacity and S phase length. Nat. Commun. 11, 3503 (2020).","journal-title":"Nat. Commun."},{"key":"34653_CR38","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/jcp.21738","volume":"219","author":"AD Friedman","year":"2009","unstructured":"Friedman, A. D. Cell cycle and developmental control of hematopoiesis by Runx1. J. Cell Physiol. 219, 520\u2013524 (2009).","journal-title":"J. Cell Physiol."},{"key":"34653_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33947-1","volume":"8","author":"B Neveu","year":"2018","unstructured":"Neveu, B., Caron, M., Lagac\u00e9, K., Richer, C. & Sinnett, D. Genome wide mapping of ETV6 binding sites in pre-B leukemic cells. Sci. Rep. 8, 15526 (2018).","journal-title":"Sci. Rep."},{"issue":"8","key":"34653_CR40","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1111\/j.1349-7006.2008.00865.x","volume":"99","author":"T Katsumoto","year":"2008","unstructured":"Katsumoto, T., Yoshida, N. & Kitabayashi, I. Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis. Cancer Sci. 99, 1523\u20131527 (2008).","journal-title":"Cancer Sci."},{"issue":"4","key":"34653_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00062752-200107000-00003","volume":"8","author":"SW Hiebert","year":"2001","unstructured":"Hiebert, S. W., Lutterbach, B. & Amann, J. Role of co-repressors in transcriptional repression mediated by the t(8;21), t(16;21), t(12;21), and inv(16) fusion proteins. Curr. Opin. Hematol. 8, 197\u2013200 (2001).","journal-title":"Curr. Opin. Hematol."},{"key":"34653_CR42","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.1093\/nar\/gkw523","volume":"44","author":"M Fischer","year":"2016","unstructured":"Fischer, M., Grossmann, P., Padi, M. & DeCaprio, J. A. Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks. Nucleic Acids Res. 44, 6070\u20136086 (2016).","journal-title":"Nucleic Acids Res."},{"key":"34653_CR43","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1172\/JCI68557","volume":"123","author":"S Goyama","year":"2013","unstructured":"Goyama, S. et al. Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells. J. Clin. Investig. 123, 3876\u20133888 (2013).","journal-title":"J. Clin. Investig."},{"key":"34653_CR44","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1126\/science.aaa0314","volume":"347","author":"A Illendula","year":"2015","unstructured":"Illendula, A. et al. A small-molecule inhibitor of the aberrant transcription factor CBF\u03b2-SMMHC delays leukemia in mice. Science 347, 779\u2013784 (2015).","journal-title":"Science"},{"key":"34653_CR45","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1182\/blood-2008-03-147207","volume":"113","author":"L Roudaia","year":"2009","unstructured":"Roudaia, L. et al. CBF\u03b2 is critical for AML1-ETO and TEL-AML1 activity. Blood 113, 3070\u20133079 (2009).","journal-title":"Blood"},{"key":"34653_CR46","doi-asserted-by":"publisher","first-page":"e28430","DOI":"10.1371\/journal.pone.0028430","volume":"6","author":"X Cai","year":"2011","unstructured":"Cai, X. et al. Runx1 loss minimally impacts long-term hematopoietic stem cells. PLoS ONE 6, e28430 (2011).","journal-title":"PLoS ONE"},{"key":"34653_CR47","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.celrep.2016.08.082","volume":"17","author":"A Mandoli","year":"2016","unstructured":"Mandoli, A. et al. The hematopoietic transcription factors RUNX1 and ERG prevent AML1-ETO oncogene overexpression and onset of the apoptosis program in t(8;21) AMLs. Cell Rep. 17, 2087\u20132100 (2016).","journal-title":"Cell Rep."},{"key":"34653_CR48","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.ccell.2018.08.015","volume":"34","author":"N Martinez-Soria","year":"2018","unstructured":"Martinez-Soria, N. et al. The oncogenic transcription factor RUNX1\/ETO corrupts cell cycle regulation to drive leukemic transformation. Cancer Cell 34, 626\u2013642 (2018).","journal-title":"Cancer Cell"},{"key":"34653_CR49","doi-asserted-by":"publisher","first-page":"107691","DOI":"10.1016\/j.celrep.2020.107691","volume":"31","author":"M Nafria","year":"2020","unstructured":"Nafria, M. et al. Expression of RUNX1-ETO Rapidly Alters the chromatin landscape and growth of early human myeloid precursor cells. Cell Rep. 31, 107691 (2020).","journal-title":"Cell Rep."},{"key":"34653_CR50","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.20101947","volume":"208","author":"LM Heltemes-Harris","year":"2011","unstructured":"Heltemes-Harris, L. M. et al. Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acutelymphoblastic leukemia. J. Exp. Med. 208, 1135\u20131149 (2011).","journal-title":"J. Exp. Med."},{"key":"34653_CR51","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/eji.201041137","volume":"41","author":"K Lukin","year":"2011","unstructured":"Lukin, K. et al. A dose-dependent role for EBF1 in repressing non-B-cell-specific genes. Eur. J. Immunol. 41, 1787\u20131793 (2011).","journal-title":"Eur. J. Immunol."},{"key":"34653_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.stem.2009.04.019","volume":"5","author":"JW Schindler","year":"2009","unstructured":"Schindler, J. W. et al. TEL-AML1 corrupts hematopoietic stem cells to persist in the bone marrow and initiate leukemia. Cell Stem Cell 5, 43\u201353 (2009).","journal-title":"Cell Stem Cell"},{"key":"34653_CR53","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/leu.2013.345","volume":"28","author":"U Kaindl","year":"2014","unstructured":"Kaindl, U. et al. Blocking ETV6\/RUNX1-induced MDM2 overexpression by Nutlin-3 reactivates p53 signaling in childhood leukemia. Leukemia 28, 600\u2013608 (2014).","journal-title":"Leukemia"},{"key":"34653_CR54","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1158\/2159-8290.CD-19-1059","volume":"10","author":"SM Dobson","year":"2020","unstructured":"Dobson, S. M. et al. Relapse-fated latent diagnosis subclones in acute B lineage leukemia are drug tolerant and possess distinct metabolic programs. Cancer Discov. 10, 568\u2013587 (2020).","journal-title":"Cancer Discov."},{"key":"34653_CR55","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/leu.2011.17","volume":"25","author":"A Gandillet","year":"2011","unstructured":"Gandillet, A. et al. Heterogeneous sensitivity of human acute myeloid leukemia to \u03b2-catenin down-modulation. Leukemia 25, 770\u2013780 (2011).","journal-title":"Leukemia"},{"key":"34653_CR56","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.celrep.2013.11.020","volume":"5","author":"C Fellmann","year":"2013","unstructured":"Fellmann, C. et al. An optimized microRNA backbone for effective single-copy RNAi. Cell Rep. 5, 1704\u20131713 (2013).","journal-title":"Cell Rep."},{"key":"34653_CR57","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.stem.2013.09.003","volume":"13","author":"G May","year":"2013","unstructured":"May, G. et al. Dynamic analysis of gene expression and genome-wide transcription factor binding during lineage specification of multipotent progenitors. Cell Stem Cell 13, 754\u2013768 (2013).","journal-title":"Cell Stem Cell"},{"key":"34653_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"34653_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-284","volume":"15","author":"L Shen","year":"2014","unstructured":"Shen, L., Shao, N., Liu, X. & Nestler, E. Ngs.plot: Quick mining and visualization of next-generation sequencing data by integrating genomic databases. BMC Genomics 15, 284 (2014).","journal-title":"BMC Genomics"},{"key":"34653_CR60","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ram\u00edrez","year":"2016","unstructured":"Ram\u00edrez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160\u2013W165 (2016).","journal-title":"Nucleic Acids Res."},{"key":"34653_CR61","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkz114","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 47, e47 (2019).","journal-title":"Nucleic Acids Res."},{"key":"34653_CR62","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"34653_CR63","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1093\/bioinformatics\/btr189","volume":"27","author":"P Machanick","year":"2011","unstructured":"Machanick, P. & Bailey, T. L. MEME-ChIP: Motif analysis of large DNA datasets. Bioinformatics 27, 1696\u20131697 (2011).","journal-title":"Bioinformatics"},{"key":"34653_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-237","volume":"11","author":"LJ Zhu","year":"2010","unstructured":"Zhu, L. J. et al. ChIPpeakAnno: a bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics 11, 237 (2010).","journal-title":"BMC Bioinformatics"},{"key":"34653_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14743-w","volume":"11","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. An integrative ENCODE resource for cancer genomics. Nat. Commun. 11, 3696 (2020).","journal-title":"Nat. Commun."},{"key":"34653_CR66","unstructured":"Stark, R. & Brown, G. DiffBind: differential binding analysis of ChIP-Seq peak data. Bioconductor (2011)."},{"key":"34653_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"34653_CR68","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2 - Elegant graphics for data analysis (2nd Edition). J. Stat. Softw. 77 (2017).","DOI":"10.18637\/jss.v077.b02"},{"key":"34653_CR69","unstructured":"Kolde, R. Package \u2018pheatmap\u2019: pretty heatmaps. Version 1.0.12 (2019)."},{"key":"34653_CR70","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"34653_CR71","unstructured":"Crowell, H. L., Robinson, M. D., Zanotelli, V. R. T., Chevrier, S. & Bodenmiller, B. CATALYST: Cytometry dATa anALYSis Tools. R package version 1.2.0. Preprint at (2017)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34653-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34653-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34653-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T15:05:33Z","timestamp":1669129533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34653-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["34653"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-34653-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,21]]},"assertion":[{"value":"17 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7124"}}